期刊文献+

肝癌细胞中PI3K信号通路对骨桥蛋白表达的影响 被引量:1

Influence on osteopontin expression by Phosphatidylinositol 3-kinase signaling pathway in hepatocellular carcinoma cells
暂未订购
导出
摘要 目的研究磷脂酰肌醇3-激酶(PI3K)信号通路在肝癌细胞骨桥蛋白(OPN)表达调控中的作用。方法体外培养高转移性人肝癌细胞株HCCLM3,分为对照组、PI3K特异性抑制剂LY294002浓度5、10、20μmol/L组,处理6 h后,采用逆转录聚合酶链反应(RT-PCR)技术检测OPN mRNA表达的变化。结果LY294002可使肝癌细胞HCCLM3的OPN mRNA的表达下降,且这种抑制作用随着LY294002浓度增大而增大(P<0.01),呈现剂量依赖性关系。结论LY294002可以抑制肝癌细胞株HCCLM3中OPN的表达,肝癌细胞OPN的表达调控受PI3K信号通路调控。 [ Objective ] To investigate the roles of Phosphatidylinositol 3-kinase (PI3K) in the regulation of expression of osteopontin (OPN) in hepatocellular carcinoma (HCC) cells. [ Methods] The high metastasic cell line HCCLM3 were cultured in DMEM medium, HCCLM3 cells were divided into control group and LY294002 groups (5 μmol/L, 10 μmol/L, 20 μmol/L). The expression of OPN mRNA was detected by reverse transcriptional polymerase chain reaction (RT-PCR) after 6 hours. [Results] In HCCLM3 cells, the expression of OPN mRNA was apparently inhibited by LY294002. With the increase of LY294002 concentration, the expression of OPN mRNA decreased gradually (P 〈0.01 ) and in a dose-dependent manners. [ Conclusion ] LY294002 can reduce the expression of OPN mRNA in HCCLM3 cell line, and the expression of OPN in HCC cells is regulated by PI3K.
出处 《山东医药》 CAS 北大核心 2007年第27期20-21,共2页 Shandong Medical Journal
关键词 肝细胞 骨桥蛋白 磷脂酰肌醇3-激酶 carcinoma, hepatocellular osteopontin phosphatidylinositol 3-kinase
  • 相关文献

参考文献6

  • 1陆健,卞建民,时开网,樊克武,蔡永东.肝细胞癌组织中骨桥蛋白的表达及其与血管生成的关系[J].山东医药,2006,46(9):3-5. 被引量:3
  • 2Rittling SR, Chambers AF. Role of osteopontin in tumour progression [J]. Br J Cancer, 2004,90(10) :1877-1881.
  • 3Fedarko NS, Jain A, Karadag A, et al. Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer [J]. Clin Cancer Res, 2001,7(12) :4060-4066.
  • 4Pan HW, Ou YH, Peng SY, et al. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma [J]. Cancer, 2003,98(1) :119-127.
  • 5Chang F, Lee JT, Navolanic PM, et al. Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy [J]. Leukemia, 2003,17 (3) :590-603.
  • 6Junaid A, Amara FM. Osteopontin: correlation with interstitial fibrosis in human diabetic kidney and PI3-kinase-mediated enhancement of expression by glucose in human proximal tubular epithelial ceils [J]. Histopathology, 2004,44(2):136-146.

二级参考文献8

  • 1Kim JH,Skates SJ,Uede T,et al.Osteopontin as a potential diagnostic biomarker for ovarian cancer[J].JAMA,2002,287(13):1671-1679.
  • 2Agrawal D,Chen T,Irby R,et al.Osteopontin identified as lead marker of colon cancer progression,using pooled sample expression profiling[J].J Natl Cancer Inst,2002,94 (7):513-521.
  • 3Kao CL,Chiou SH,Ho DM,et al.Elevation of plasma and cerebrospinal fluid osteopontin levels in patients with atypical teratoid/rhabdoid tumor[J].Am J Clin Pathol,2005,123 (2):297-304.
  • 4Coppola D,Szabo M,Boulware D,et al.Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies[J].Clin Cancer Res,2004,10 (1):184-190.
  • 5Pan HW,Ou YH,Peng SY,et al.Overexpression of osteopontin is associated with intrahepatic metastasis,early recurrence,and poorer prognosis of surgically resected hepatocellular carcinoma[J].Cancer,2003,98(1):119-127.
  • 6Peng SY,Ou YH,Chen WJ,et al.Aberrant expressions of annexin A10 short isoform,osteopontin and alpha-fetoprotein at chromosome 4q cooperatively contribute to progression and poor prognosis of hepatocellular carcinoma[J ].Int JOncol,2005,26(4):1053-1061.
  • 7Gotoh M,Sakamoto M,Kanetaka K,et al.Overexpression of osteopontin in hepatocellular carcinoma[J].Pathol Int,2002,52(1):19-24.
  • 8盛红光,张敏,姜言明,寿楠海.微血管密度与肝细胞癌侵袭性关系的研究[J].山东医药,2004,44(9):1-2. 被引量:2

共引文献2

同被引文献10

引证文献1

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部